SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-062529
Filing Date
2009-11-16
Accepted
2009-11-13 21:29:44
Documents
4
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c92525e10vq.htm 10-Q 157239
2 EXHIBIT 31.1 c92525exv31w1.htm EX-31.1 8863
3 EXHIBIT 31.2 c92525exv31w2.htm EX-31.2 9108
4 EXHIBIT 32.1 c92525exv32w1.htm EX-32.1 5287
  Complete submission text file 0000950123-09-062529.txt   181904
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 091183362
SIC: 2836 Biological Products, (No Diagnostic Substances)